These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
326 related articles for article (PubMed ID: 26468391)
21. Decreased Eph receptor‑A1 expression is related to grade in ovarian serous carcinoma. Jin Y; Zou Y; Wan L; Lu M; Liu Y; Huang G; Wang J; Xi Q Mol Med Rep; 2018 Apr; 17(4):5409-5415. PubMed ID: 29393455 [TBL] [Abstract][Full Text] [Related]
22. Nicotinamide N-methyltransferase overexpression may be associated with poor prognosis in ovarian cancer. Harmankaya İ; Akar S; Uğraş S; Güler AH; Ezveci H; Aydoğdu M; Çelik Ç J Obstet Gynaecol; 2021 Feb; 41(2):248-253. PubMed ID: 32285726 [TBL] [Abstract][Full Text] [Related]
24. Loss of expression of EphB1 protein in serous carcinoma of ovary associated with metastasis and poor survival. Wang H; Wen J; Wang H; Guo Q; Shi S; Shi Q; Zhou X; Liu Q; Lu G; Wang J Int J Clin Exp Pathol; 2014; 7(1):313-21. PubMed ID: 24427352 [TBL] [Abstract][Full Text] [Related]
25. Overexpression of β-catenin and cyclinD1 predicts a poor prognosis in ovarian serous carcinomas. Wang H; Wang H; Makki MS; Wen J; Dai Y; Shi Q; Liu Q; Zhou X; Wang J Int J Clin Exp Pathol; 2014; 7(1):264-71. PubMed ID: 24427347 [TBL] [Abstract][Full Text] [Related]
26. Glycodelin in ovarian serous carcinoma: association with differentiation and survival. Mandelin E; Lassus H; Seppälä M; Leminen A; Gustafsson JA; Cheng G; Bützow R; Koistinen R Cancer Res; 2003 Oct; 63(19):6258-64. PubMed ID: 14559812 [TBL] [Abstract][Full Text] [Related]
27. Expression of hypothalamic-pituitary-gonadal axis-related hormone receptors in low-grade serous ovarian cancer (LGSC). Feng Z; Wen H; Ju X; Bi R; Chen X; Yang W; Wu X J Ovarian Res; 2017 Jan; 10(1):7. PubMed ID: 28122595 [TBL] [Abstract][Full Text] [Related]
28. [The morphological and immunohistochemical characteristics of changes in the fallopian tube mucosa in ovarian epithelial tumors]. Asaturova AV; Ezhova LS; Faizullina NM; Sannikova MV; Khabas GN Arkh Patol; 2016; 78(2):3-9. PubMed ID: 27070769 [TBL] [Abstract][Full Text] [Related]
29. Outcome in serous ovarian cancer is not associated with LATS expression. Montavon C; Stricker GR; Schoetzau A; Heinzelmann-Schwarz V; Jacob F; Fedier A J Cancer Res Clin Oncol; 2019 Nov; 145(11):2737-2749. PubMed ID: 31586262 [TBL] [Abstract][Full Text] [Related]
30. Variation in cell signaling protein expression may introduce sampling bias in primary epithelial ovarian cancer. Mittermeyer G; Malinowsky K; Beese C; Höfler H; Schmalfeldt B; Becker KF; Avril S PLoS One; 2013; 8(10):e77825. PubMed ID: 24204986 [TBL] [Abstract][Full Text] [Related]
31. MDM2 Expression in Serous and Mucinous Epithelial Tumours of the Ovary. Abdelaal SE; Habib FM; El Din AA; Gabal SM; Hassan NS; Ibrahim NA Asian Pac J Cancer Prev; 2016; 17(7):3295-300. PubMed ID: 27509966 [TBL] [Abstract][Full Text] [Related]
32. Expression profile of tight junction protein claudin 3 and claudin 4 in ovarian serous adenocarcinoma with prognostic correlation. Choi YL; Kim J; Kwon MJ; Choi JS; Kim TJ; Bae DS; Koh SS; In YH; Park YW; Kim SH; Ahn G; Shin YK Histol Histopathol; 2007 Nov; 22(11):1185-95. PubMed ID: 17647191 [TBL] [Abstract][Full Text] [Related]
33. Xu Z; Zhuang L; Wang X; Li Q; Sang Y; Xu J Future Oncol; 2020 Sep; 16(25):1921-1930. PubMed ID: 32915667 [No Abstract] [Full Text] [Related]
34. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma. Salvador S; Rempel A; Soslow RA; Gilks B; Huntsman D; Miller D Gynecol Oncol; 2008 Sep; 110(3):408-17. PubMed ID: 18597838 [TBL] [Abstract][Full Text] [Related]
35. [Correlation of hK6 expression with clinicopathological features and prognosis in epithelial ovarian cancer]. Hu CJ; Zhang F; Chen YJ; Sun XM; Zheng JF Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):520-3. PubMed ID: 19950700 [TBL] [Abstract][Full Text] [Related]
36. [The Fallopian tube odyssey: from the ovary to the tube. About high-grade serous ovarian carcinoma]. Chêne G; Dauplat J; Radosevic-Robin N; Cayre A; Penault-Llorca F Bull Cancer; 2013; 100(7-8):757-64. PubMed ID: 23831931 [TBL] [Abstract][Full Text] [Related]
37. Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis. McCluggage WG Pathology; 2011 Aug; 43(5):420-32. PubMed ID: 21716157 [TBL] [Abstract][Full Text] [Related]
38. Meta-analysis of transcriptome reveals let-7b as an unfavorable prognostic biomarker and predicts molecular and clinical subclasses in high-grade serous ovarian carcinoma. Tang Z; Ow GS; Thiery JP; Ivshina AV; Kuznetsov VA Int J Cancer; 2014 Jan; 134(2):306-18. PubMed ID: 23825028 [TBL] [Abstract][Full Text] [Related]
39. Detection of serous precursor lesions in resected fallopian tubes from patients with benign diseases and a relatively low risk for ovarian cancer. Nishida N; Murakami F; Higaki K Pathol Int; 2016 Jun; 66(6):337-42. PubMed ID: 27250113 [TBL] [Abstract][Full Text] [Related]
40. Overexpression of ICAM-1 Predicts Poor Survival in High-Grade Serous Ovarian Carcinoma: A Study Based on TCGA and GEO Databases and Tissue Microarray. Wang S; Yin C; Zhang Y; Zhang L; Tao L; Liang W; Pang L; Fu R; Ding Y; Li F; Jia W Biomed Res Int; 2019; 2019():2867372. PubMed ID: 31312656 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]